Human C-ERBB-2 proto-oncogene product as
โ
Takashi Nishimura; Yoshihiko Nakamura; Hideo Tsukamoto; Yasuhiro Takeuchi; Yutak
๐
Article
๐
1992
๐
John Wiley and Sons
๐
French
โ 559 KB
To develop an efficient strategy for the targeting of antitumor effector cells, we prepared bispecific antibody (BsAb) containing anti-CD3 and an anti-c-erbB-2 proto-oncogene product. The prepared BsAb specifically reacts with both c-erb6-2positive tumor cells and CD3+ CTL. Human CD4' helper/killer